1. Editor's page

   EditorialNotes Pages: 75 - 75

2. High point

   • Elwood V. Jensen

   Special Feature Pages: 77 - 86

3. Drug dosage intensity — a panel discussion

   • William L McGuire
   • James Goldie
   • Douglass C Tormey

   Viewpoints Pages: 87 - 100

4. Nuclear DNA content and prognosis in human breast cancer: A static cytophotometric study

   • Jennet Harvey
   • Nicholas de Klerk
   • John Papadimitriou

   Report Pages: 101 - 109

5. Biological differences among MCF-7 human breast cancer cell lines from different laboratories

   • C. Kent Osborne
   • Kimberly Hobbs
   • Jeffrey M. Trent

   Report Pages: 111 - 121

6. Progesterone binding cyst protein (PBCP) in primary breast cancer: A new prognostic factor?

   • Jon Arne Søreide
   • Oscar A. Lea
   • Stener Kvinnsland

   Report Pages: 123 - 128

7. Oestrogen receptor activity in intraduct and invasive breast carcinomas

   • R. A. Hawkins
   • A. L. Tesdale
   • J. J. Going

   Report Pages: 129 - 133

8. Social and biological factors in relation to survival among black vs. white women with breast cancer

   • Barbara Valanis
   • John Wirman
   • Vicki Stover Hertzberg

   Report Pages: 135 - 143

9. Influence of height, weight, and obesity on breast cancer incidence and recurrence in Auckland, New Zealand

   • Raewyn K. McNee
   • Barbara H. Mason
   • Ronald G. Kay

   Report Pages: 145 - 150

10. Estrogenic effects of phenolphthalein on human breast cancer cellsin vitro

    • Peter Marcus Ravdin
    • Marc van Beurden
    • V. Craig Jordan

    Brief communication Pages: 151 - 154

11. Retrovirus association with breast cancer: A critical appraisal

    • Arnold S. Dion

    Meeting report Pages: 155 - 156

12. Long-term adjuvant tamoxifen study: Clinical update

    • Douglass C. Tormey
    • P. Rasmussen
    • V. Craig Jordan

    Correspondence Pages: 157 - 158

13. Announcements

    Announcement Pages: 159 - 160